Market Closed -
Nasdaq
16:00:00 2024-05-17 EDT
|
5-day change
|
1st Jan Change
|
7.06
USD
|
+5.53%
|
|
+14.05%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
338
|
-
|
-
|
Enterprise Value (EV)
1 |
562.9
|
500.8
|
518.2
|
P/E ratio
|
-3.25
x
|
-2.89
x
|
-
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
10,243
x
|
68.8
x
|
50.3
x
|
EV / Revenue
|
17,058
x
|
102
x
|
77.1
x
|
EV / EBITDA
|
-6.8
x
|
-4.05
x
|
-2.81
x
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
-1.12
x
|
-1.52
x
|
-1.82
x
|
Nbr of stocks (in thousands)
|
47,878
|
-
|
-
|
Reference price
2 |
7.060
|
7.060
|
7.060
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
0.12
|
0.033
|
4.912
|
6.717
|
EBITDA
1 |
-
|
-
|
-82.76
|
-123.6
|
-184.6
|
EBIT
1 |
-
|
-50.84
|
-83.35
|
-112.8
|
-167.5
|
Operating Margin
|
-
|
-42,363.33%
|
-252,575.12%
|
-2,296.47%
|
-2,493.55%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-46.45
|
-94.27
|
-81.99
|
-127.8
|
-
|
Net margin
|
-
|
-78,559.17%
|
-248,442.42%
|
-2,602.48%
|
-
|
EPS
2 |
-14.90
|
-
|
-2.170
|
-2.440
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23-08-22
|
24-04-01
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
225
|
163
|
180
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-2.718
x
|
-1.317
x
|
-0.9758
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-6.290
|
-4.630
|
-3.880
|
Cash Flow per Share
2 |
-
|
-
|
-1.850
|
-2.190
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23-08-22
|
24-04-01
|
-
|
-
|
-
|
Last Close Price
7.06
USD Average target price
22
USD Spread / Average Target +211.61% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 338M | | +9.42% | 115B | | +11.84% | 106B | | -2.47% | 21.96B | | -14.15% | 21.87B | | -5.29% | 19.21B | | -4.16% | 18.08B | | -38.29% | 17.71B | | +7.99% | 14.32B | | +36.24% | 12.42B |
Bio Therapeutic Drugs
|